Shandong Sinobioway Biomedicine Co Ltd (002581) — Financial Flexibility Index
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of CN¥-26.32 Million (operating CF CN¥-86.58 Million minus capex CN¥60.26 Million) represents 0% of total liabilities (CN¥221.51 Million). Check how aggressively does Shandong Sinobioway Biomedicine Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shandong Sinobioway Biomedicine Co Ltd Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Shandong Sinobioway Biomedicine Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see 002581 operating cash flow.
Annual Financial Flexibility Index for Shandong Sinobioway Biomedicine Co Ltd (2007–2024)
Year-by-year free cash flow to debt coverage for Shandong Sinobioway Biomedicine Co Ltd. Explore Shandong Sinobioway Biomedicine Co Ltd (002581) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.01x | CN¥2.47 Million | CN¥-6.55 Million | CN¥173.61 Million | ▲ +107.2% |
| 2023 | -0.20x | CN¥-32.19 Million | CN¥-36.51 Million | CN¥163.41 Million | ▼ -233.2% |
| 2022 | -0.06x | CN¥-23.02 Million | CN¥-54.49 Million | CN¥389.46 Million | ▼ -214.3% |
| 2021 | 0.05x | CN¥14.83 Million | CN¥-46.02 Million | CN¥286.76 Million | ▼ -84.7% |
| 2020 | 0.34x | CN¥86.21 Million | CN¥18.51 Million | CN¥254.33 Million | ▲ +310.3% |
| 2019 | 0.08x | CN¥84.69 Million | CN¥48.41 Million | CN¥1.03 Billion | ▼ -82.2% |
| 2018 | 0.46x | CN¥682.72 Million | CN¥74.46 Million | CN¥1.47 Billion | ▲ +39.2% |
| 2017 | 0.33x | CN¥359.24 Million | CN¥271.11 Million | CN¥1.08 Billion | ▼ -75.1% |
| 2016 | 1.34x | CN¥214.00 Million | CN¥169.32 Million | CN¥160.16 Million | ▲ +98.2% |
| 2015 | 0.67x | CN¥183.34 Million | CN¥137.73 Million | CN¥271.92 Million | ▼ -86.6% |
| 2014 | 5.01x | CN¥100.70 Million | CN¥80.11 Million | CN¥20.08 Million | ▲ +41.8% |
| 2013 | 3.54x | CN¥125.54 Million | CN¥83.13 Million | CN¥35.49 Million | ▼ -30.4% |
| 2012 | 5.08x | CN¥125.15 Million | CN¥63.04 Million | CN¥24.62 Million | ▼ -10.3% |
| 2011 | 5.67x | CN¥101.58 Million | CN¥74.43 Million | CN¥17.91 Million | ▲ +58.9% |
| 2010 | 3.57x | CN¥115.39 Million | CN¥85.71 Million | CN¥32.34 Million | ▲ +80.4% |
| 2009 | 1.98x | CN¥69.69 Million | CN¥54.06 Million | CN¥35.24 Million | ▼ -30.5% |
| 2008 | 2.85x | CN¥78.00 Million | CN¥46.89 Million | CN¥27.41 Million | ▲ +6.6% |
| 2007 | 2.67x | CN¥30.98 Million | CN¥25.07 Million | CN¥11.60 Million | — |